期刊文献+

LKB1和VEGFR_2评价肺腺癌预后的意义 被引量:5

Prognostic significance of LKB1 and VEGFR_2 in patients with lung adenocarcinoma
下载PDF
导出
摘要 目的探讨LKB1、VEGFR2在肺腺癌中的表达情况,分析其预后意义。方法应用免疫组化方法检测46例肺腺癌中LKB1、VEGFR2的表达情况。结果 LKB1在癌旁正常肺组织、淋巴结转移阴性组肺腺癌、Ⅰ~Ⅱ期肺腺癌中的表达阳性率明显高于肺腺癌组织、淋巴结转移阳性组肺腺癌和ⅢA期肺腺癌(82.61%vs 63.04%、75.00%vs 44.44%、75.00%vs35.71%),差异有统计学意义(P<0.05)。VEGFR2在癌旁正常肺组织、淋巴结转移阴性组肺腺癌、Ⅰ~Ⅱ期肺腺癌中的表达阳性率则明显低于肺腺癌组织、淋巴结转移阳性组肺腺癌和ⅢA期肺腺癌(34.78%vs 58.70%、46.43%vs 77.78%、46.88%vs85.71%),差异有统计学意义(P<0.05)。结论 LKB1、VEGFR2在肺腺癌中的表达情况可能与肺腺癌患者的预后有关,LKB1低表达、VEGFR2高表达可能提示预后不良。 Objective To investigate the expression of LKB1 and VEGFR2 in patients with lung adenoearcinoma and its prognos- tic significance. Methods The expression of LKB1 and VEGFR2 in 46 patients with lung adenocarcinoma were detected by immunohisto- chemical staining. Results The positive rate of LKB1 protein in adjacent normal lung tissue, lymph node negative metastasis lung adeno- carcinoma and stage Ⅰ-Ⅱ lung adenocarcinoma were significantly higher than that in tumor lung tissue, positive lymph node metastasis lung adeaocareinoma and stage ⅢA lung adenocarcinoma (82.61% vs 63.04% , 75.00% vs 44.44% and 75.00% vs 35.71% respec- tively, P 〈0. 05 ). The expression of VEGFR2 in adjacent normal lung tissue, lymph node negative metastasis lung adenocarcinoma and stage Ⅰ-Ⅱ lung adenocarcinoma were significantly lower than that in tumor lung tissue, positive lymph node metastasis lung adenocarci- noma and stage mA lung adenocarcinoma ( 34. 78% vs 58.70% , 46. 43% vs 77.78% and 46. 88% vs 85.71% respeetively, P 〈 0.05 ). Conclusion The expression of LKB1 and VEGFR2 may be related to the prognosis of patients with lung adenocarcinoma. Low expression of LKBI and high expression of VEGFR2 may reflect the poor prognosis of patients with lung adenocarcinoma.
出处 《临床肺科杂志》 2013年第6期1096-1097,共2页 Journal of Clinical Pulmonary Medicine
关键词 LKB1 VEGFR2 腺癌 预后 LKB1 VEGFR2 adenocarcinoma lung prognosis
  • 相关文献

参考文献11

  • 1Stack-Davis J, Dasilva JO, Parsons SJ. LKB1 and Sro: Antagonis-tic Regulators of Tumor Growth and Metastasis [ J ]. Cancer Cell,2010, 17(6) : 527 -529.
  • 2Liang X, Nan KJ, Li ZL, et al. Overexpression of the LKB1 geneinhibits lung carcinoma cell proliferation partly through degradationof c-myc protein[ J] . Oncol Rep, 2009 , 21(4) : 925 -931.
  • 3Ji HB, Ramsey MR, Hayes DN, et al. LKB1 modulates lung canc-er differentiation and metastasis [ J ]. Nature, 2007 , 448(7155):807 -810.
  • 4Gill RK, Yang SH, Meerzaman D, et al. Frequent homozygous de-letion of the LKB1/STK11 gene in non-small cell lung cancer[ J ].Oncogene, 2011, 30(35):3784 -3791.
  • 5Osoegawa A, Kometani T, Nosaki K, et al. T.KBl mutations fre-quently detected in mucinous bronchioloalveolar carcinoma[ J]. JpnJ Clin Oncol, 2011,41(9) :1132 - 1137.
  • 6Ghaffar H,Sahin F, Sanchez-Cepedes M, et al. LKB1 protein ex-pression in the evolution of glandular neoplasia of the lung [ J ].Clin Cancer Res 2003,9(8) :2998 -3003.
  • 7Gralzinger D, Advani R , Zhao S,et al. Lymphoma cell VEGFR2expression detected by immunohistochemistry predicts poor overallsurvival in diffuse large B cell lymphoma treated with immunoche-motherapy ( R-CHOP) [ J]. Br J Haematol,2010,148(2):235 -244.
  • 8Sanchez - Cespedes M,Parrella P,Esteller M,et al. Inactivation ofLKB1/STK11 is a common event in adenocarcinomas of the lung[J], Cancer Res,2002,62(13) :3659 -3662.
  • 9刘钊,周斌,赵坚,胡晔,朱昌生,张毅.VEGF-C和VEGFR-3在非小细胞肺癌癌组织及癌旁组织中的表达及意义[J].临床肺科杂志,2010,15(9):1217-1219. 被引量:7
  • 10Guo S, Colbert LS,Fuller M, et al. Vascular endothelial growthfactor receptor-2 in breast cancer [ J ]. Biochim Biophys Acta,2010,1806(1) : 108-121.

二级参考文献17

  • 1Kaipainen A,Korhonen J,Mustonen T,et al.Expression of the like tyrosine gene become to lymphatic endothelium during development[J].Proc Nati Acad Sci USA,1995,92(8):1599-1604.
  • 2Agnes Fetal.Genomic organization of the extra cellular coding region of the human VEGF and FLT4 genes:evolution of the genes encoding receptor tyrosine with immunoglobulin-like domains[J].J Mol,1997,45:432.
  • 3Van Trappen,Steele D,Lowe DG,et al.Expression of vascular endothelial growth factor(VEGF)-C and VEGF-D and their receptor VEGFR-3,during different stages of cervical carcinogenesis[J].J Pat,2003,201(4):544-554.
  • 4Mandriota S J,Jussila L,Jetsch M,et al.Vascular endothelial growth factor-C mediated Lymph angiogenesis promotes tumor metastasis[J].EMBO J,2001,20(7):672-682.
  • 5Veikkola T,Jussila L,Makinen et al.Significance Via Vascular endothelial growth factor-3 is sufficient for Lymph angiogenesis in transgenic mice[J].EMBO J,2001,20(7):1223-1231.
  • 6Schoppmann SF,Birner P,Stock J,et al.Tumor-associated macrophages express lymphatic endothelial growth factors and related to peritumoral lymph angiogenesis[J].Am J Path,2002,161(30):947-956.
  • 7Makinen T,Jussila L,Veikkola T,et al.Inhibition of lymph angiogenesis with resulting lymph edema in transgenic mice expressing VEGF receptor-3[J].Nature Med,2001,7(2):199-205.
  • 8Stacker SA,Caesar C,Baldwin ME,et al.VEGF-D promotes spread of tumor cells via the lymphatic[J].Nat Med,2004,7(2):186-191.
  • 9Muller A,Homey B,Soto H,et al.Involvement of chemo receptors in breast cancer metastasis[J].Nature,2005,410(6824):50-56.
  • 10Brown LF,Berse B,Jackman RW,et al.Expression of vascular permeability factor(vascular endothelial growth factor)and its receptors in breast cancer[J].Hum Path,2006,26(1):86-88.

共引文献67

同被引文献82

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部